Live feed
Filing
SC 13D
SC 13D0001104659-21-093091·Acumen Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Acumen Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00509G209
Event date: 2021-07-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,770,773
- Percent of class
- 25.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-093091
- Form type
- SC 13D
- Filer
- Acumen Pharmaceuticals, Inc.
- CIK
- CIK 1576885
- Filed
- Jul 16, 2021
- Reporting period
- Jul 06, 2021
- Description
- Schedule 13D beneficial ownership